Paris, May 21, 2009
Multiresistance of bacteria to antibiotics is a phenomenon that appeared when these drugsbegan to be used in the 1950s. It was subsequently discovered that resistance genes wereeasily captured, disseminated and exchanged from one bacterium to another by a systeminvolving genetic "copying and pasting" of the structures containing these genes, known asintegrons. But the dynamics of these exchanges, which governs the multiresistancedevelopment in bacteria, remained unknown.
The work of researchers from the Institut Pasteur associated with the CNRS (BacterialGenome Plasticity unit, CNRS URA 2171) and from Inserm, within the Limoges Faculty ofMedicine (EA3175, Inserm, Avenir Team), in cooperation with Spanish teams, reveals for thefirst time today how bacteria acquire these multiresistance properties. It is actually theantibiotics themselves that trigger the synthesis of the bacterial enzyme that captures theresistance genes and enables their expression in the integron.
This enzyme also promotes the random rearrangement of the resistance genes within theintegron. The order of these genes in the integron determines the degree of priority for theirexpression: the first are expressed most highly and give the bacteria the correspondingresistance. The last remain silent, although they are kept in reserve. When a newrearrangement occurs, triggered by taking an antibiotic, for example, they are likely to bemoved to the first positions, and give the bacteria the required resistance to this drug. Thebacteria with the right "combination" of genes will therefore be able to survive and ensurethat the resistance potential is maintained from generation to generation.
This work shows the extent to which strategies of bacterial adaptation to antibiotics areeffective, in both the short and the long term. It therefore clearly demonstrates the difficultiesassociated with bacterial genetics that future public health measures will have to take intoaccount if they are to tackle the problem of multiresistance.
The SOS response controls integron recombination, Science, May 22, 2009.
Émilie Guerin(1)*, Guillaume Cambray(2)*, Neus Sanchez-Alberola(3)*, Susana Campoy(3), Ivan Erill(4), Sandra Da Re(1), Bruno Gonzalez-Zorn(5), Jordi Barbé(3), Marie-Cécile Ploy(1), Didier Mazel(2)
(1) Univ. Limoges, Faculty of Medicine, EA3175; Inserm, Avenir Team, Limoges, France
(2) Institut Pasteur, Bacterial Genome Plasticity, CNRS URA 2171, Paris, France
(3) Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Spain
(4) Biomedical Applications Group, Centro Nacional de Microelectrónica (CNM-IMB, CSIC), Barcelona, Spain
(5) Department of Animal Health, Veterinary Faculty, Universidad Complutense de Madrid, Spain.
*Equal contribution from these authors.
Latest press releases